Ipratropium Bromide Monohydrate
Ipratropium Bromide Monohydrate is an anticholinergic bronchodilator medication used primarily to treat respiratory conditions by relaxing airway smooth muscle. It is commonly prescribed for chronic obstructive pulmonary disease (COPD) and as an adjunct therapy in asthma management. The medication is typically administered via inhalation using a metered-dose inhaler or nebulizer.
Ipratropium Bromide Monohydrate is an inhaled anticholinergic medication that opens airways to improve breathing in COPD and asthma.
Key facts at a glance
- RxNorm
- 1309404
- Generic
- Ipratropium Bromide Monohydrate
- Class
- pin-variant
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Ipratropium Bromide is used to manage and treat bronchospasm associated with COPD (including chronic bronchitis and emphysema) and as adjunctive therapy for asthma when used with beta-agonists. It is also available in nasal spray form for rhinorrhea associated with allergic and non-allergic rhinitis.
As an anticholinergic (antimuscarinic) agent, ipratropium blocks muscarinic acetylcholine receptors in bronchial smooth muscle. This prevents acetylcholine-mediated bronchoconstriction, leading to bronchodilation and improved airflow. The medication acts locally on airways with minimal systemic absorption.
Ipratropium is not a rescue medication for acute bronchospasm and should not replace corticosteroids in asthma management. Common side effects may include dry mouth, throat irritation, and headache. Patients with narrow-angle glaucoma or urinary retention should use cautiously. Effects typically begin within 15-30 minutes and last 3-6 hours.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 28, 2026. · Read our editorial policy